Michael I Sponfeldner

5PUBLICATIONS
33CO-AUTHORS
Toxicology (incl. clinical toxicology)Molecular targetsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 16, 2026
Development and analysis of a SmPC-based machine-readable dataset of contraindications for clinical decision support and real-world data analysis.

|Jul 01, 2026
Young Investigator Award 2026: Extent and incidence of pseudo-worsening of kidney function due to oral antitumor therapeutics in the AMBORA cohort: an analysis of real-world data.

|Dec 22, 2025
Extent and Incidence of Pseudo-Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real-World Data.

Michael I Sponfeldner, Pauline Dürr, Phyllis Lensker

|Nov 08, 2024
Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in "Summaries of Product Characteristics".

Wahram Andrikyan, Michael I Sponfeldner, Lea Jung-Poppe

|Jul 11, 2024
Pseudo-Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPC.

Michael I Sponfeldner, Wahram Andrikyan, Renke Maas

Pageof 1

Frequent Collaborators

4 joint publications

Martin F Fromm

3 joint publications

Wahram Andrikyan

3 joint publications

Renke Maas

2 joint publications

Pauline Dürr